A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours
2017 · British Journal of Cancer · 77 citations
https://doi.org/10.1038/bjc.2017.36
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
2.1K
Citations
17
h-index
21
i10-index
Sarah Jaw‐Tsai is an academic researcher. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Radiopharmaceutical Chemistry and Applications & HER2/EGFR in Cancer Research. The author has an h-index of 17, co-authored 53 publications.
Click to start Chat